Skip to ContentSkip to Navigation
founded in 1614  -  top 100 university
About us Practical matters How to find us drs. B. van Essen-Eisses

Publications

18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort Trial

Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer

Imaging-derived biomarkers in metastatic breast cancer: towards optimizing personalized treatment strategies

Automated Whole-Body PET/CT Lesion Tracking for Lesion-Wise Response Evaluation in Metastatic Breast Cancer

Clinical utility of molecular imaging in newly diagnosed metastatic breast cancer.

Correlation between Histopathological Prognostic Tumor Characteristics and [18F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer

Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer

[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to predict watchful waiting duration in patients with metastatic clear cell renal cell carcinoma

Non-invasive estrogen receptor assessment by [F-18]-fluorestradiol(FES)-PET or circulating tumor cells predicts receptor status in patients with metastatic breast cancer

Molecular Imaging in Cancer Drug Development

Press/media

FDG-PET predicts outcomes in metastatic breast cancer